Differential expression of the transfected liver-specific alpha 1-inhibitor III gene in normal hepatocytes and hepatoma cells in culture

Biochem Biophys Res Commun. 1992 Feb 28;183(1):184-92. doi: 10.1016/0006-291x(92)91626-2.

Abstract

Normal and malignant hepatocytes were transfected during log phase culture with a nested series of DNA plasmids containing 5'-flanking regions of the rat liver-specific acute phase plasma proteinase alpha 1-inhibitor III (alpha 1 I3) gene. Under these conditions, luciferase reporter gene expression in primary adult rat and mouse hepatocytes was 10-fold higher than luciferase expression in hepatoma lines (human HepG2 and Hep3B; rat FAZA). Optimal expression in primary rat hepatocytes required regions stretching 2214 bp 5'-upstream of the transcription start site. Shorter 5'-flanking sequences were optimal for expression in hepatoma cells (-1025 and -186 bp for rat and human lines, respectively) and primary mouse hepatocytes (-225 bp). In contrast, regions from -186 to -225 bp drove luciferase expression in primary rat hepatocytes, but only 20-75% of optimal levels. Qualitative differences were unaccounted for by non-equivalent uptake of plasmid DNA, suggesting that tissue specific gene expression is regulated differently in normal and malignant cells, and with apparent species specificity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute-Phase Proteins*
  • Animals
  • Blood Proteins / genetics*
  • Cells, Cultured
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Liver / cytology
  • Liver / metabolism*
  • Liver Neoplasms, Experimental / metabolism
  • Male
  • Protease Inhibitors / metabolism*
  • Rats
  • Recombinant Fusion Proteins
  • Regulatory Sequences, Nucleic Acid / genetics*
  • Transfection
  • Transforming Growth Factor alpha / pharmacology

Substances

  • Acute-Phase Proteins
  • Blood Proteins
  • Protease Inhibitors
  • Recombinant Fusion Proteins
  • Transforming Growth Factor alpha
  • alpha 1-inhibitor 3